"Britain has long valued, & thrived from, academic freedom. This is not the 1960s McCarthy era"
Professor of politics
"What we're trying to do is provide the solid data, together with the satellites, that will tell us how the atmosphere is changing"
Head of Ozone Group, Deutscher Wetterdienst
"This study shows how governments in Europe ... are fuelling dangerous climate change and air pollution with taxpayers’ money.""
Overseas Development Institute
"Threatening to indiscriminately slaughter hundreds of thousands of civilians to protect ourselves is a stupid idea."
Executive Director, ICAN
"“This is a Christian country... If you go to Turkey or Saudi Arabia and start to discredit Islam, the reaction will be the same”"
Student who fled to Austria from Chechnya
"Thousands of seeds of a single species can be kept alive for tens or hundreds of years""
Maria Manuela Sim-Sim
Curator, Seed Bank A. L. Belo Correia
"He has independence at his core. It is not something that he has improvised"
Friend of Carles Puigdemont
"There will be no cheating. The process is set in a way that you can't cheat. Even at the precinct, the walls of the precinct or the doors of the polling places we will have the results posted."
Watch Euronews live stream
Under mounting pressure, pharmaceutical company Mylan says it will slash the costs of emergency EpiPens for some patients in the US.
Pfizer has outbid Sanofi to buy the US cancer drug company Medivation, thereby acquiring the prostate cancer treatment Xtandi.
Monsanto has rejected an offer worth $62 billion (55.6 billion euros) from Bayer trying to create the world's biggest agricultural supplier.
Germany's Bayer has offered to buy US seeds company Monsanto for $62 billion (55 billion euros) in cash trying to gain the top spot in the fast-consolidating farm supplies industry.
Drug companies are saying No to death row. The latest pharmaceuticals giant to restrict sales of drugs used in lethal injections to US prisons is
The US Treasury has tightened its rules to prevent companies moving abroad to avoid US taxes. The immediate effect has been for the number one
French drugmaker Sanofi has pledged its 2016 earnings will be stable despite declining sales of diabetes and cancer treatments.
A former pharmaceuticals chief, who hiked the price of a life-saving medicine by more than five thousand percent, has refused to testify in front of
Gavi, an alliance committed to saving lives through vaccination, has put up $5 million for future purchases of a vaccine from US drugmaker Merck Sharp & Dohme to help take it through late-stage clinic
A man left brain dead after a clinical trial in France has now died. He was one of dozens of volunteers at a private facility to have tested an
A patient has died after falling into a coma following a medical trial in Rennes, northwest France. Five other people were hospitalised following the
It appears karma may have caught up with US entrepreneur Martin Shkreli, who has been arrested on fraud charges. In 2015 he became the internet’s
A British pharmaceuticals giant has been forced to pull a bestselling product from the shelves in Australia after a court order. Judges ruled Reckitt
A potent mix of Viagra and Botox is on the cards: their makers have agreed the healthcare sector’s biggest ever takeover deal. The transaction to
It’s worth over seven billion dollars – a Californian biotech company that makes drugs aimed at treating cancer, heart disease and neurological
The Irish-based group Allergan is in talks with Pfizer over a possible merger that would unite the US makers of Botox and Viagra – and create the
With an outstanding 1.1. billion euro bill to the pharmaceutical industry, there are fears that Greece could run out of medicine within three
Antibiotics have saved countless lives since the discovery of penicillin in 1928, but their indiscriminate use means some diseases have become
“A significant step in advancing Shire’s strategy to become a leading biotechnology company.” That’s how chief executive Flemming Ornskov described
Botox producer Allergan has accepted a $66 bn takeover bid by Actavis.
The deal ends a nine-month pursuit of Allergan by the Canadian company
Watch Euronews live stream